Physician profile
Tim A Sidor
NPI 1154399483
$6,234.31
in general payments reported to CMS, 2019-2025
43 companies · $468 in 2025
The $468 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,627 · 2020: $736 · 2021: $462 · 2022: $352 · 2023: $481 · 2024: $108 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,053 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.68 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $3,107.64 | 2019-2023 | Myrbetriq, Xtandi |
| Janssen Biotech, INC. | $286.28 | 2019-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $278.75 | 2019-2024 | |
| Amgen INC. | $255.41 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $246.46 | 2023-2025 | Gemtesa, Orgovyx |
| Allergan, INC. | $168.30 | 2019-2022 | |
| Abbvie INC. | $160.44 | 2019-2025 | Botox |
| Dendreon Pharmaceuticals LLC | $156.69 | 2019-2022 | |
| Blue Earth Diagnostics | $156.19 | 2019-2024 | |
| C. R. Bard, INC. & Subsidiaries | $135.75 | 2023 | Bard Urinary Drainage Bag |
| Antares Pharma, INC. | $109.00 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $88.24 | 2023-2024 | Trelstar |
| Medtronic, INC. | $84.93 | 2025 | Interstim |
| Ferring Pharmaceuticals INC. | $80.61 | 2019-2020 | |
| Bard Access Systems, INC. | $68.67 | 2019 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Sidor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.